Compare ETFs: BIB
BIB
Comparison
Average Return
| Symbol | Year-to-date | 1 Year | 5 Years | 10 Years | Inception |
|---|---|---|---|---|---|
| BIB | -14.98% | -24.04% | -8.53% | -6.34% | 12.51% |
Top 25 Holdings
| BIB - ProShares Ultra Nasdaq Biotechnology | |||
|---|---|---|---|
| No. | Symbol | Name | Weight |
| 1 | B.0 05.27.25 | United States Treasury Bills 0% | 17.75% |
| 2 | B.0 06.20.25 | United States Treasury Bills 0% | 10.62% |
| 3 | B.0 05.20.25 | United States Treasury Bills 0% | 9.48% |
| 4 | B.0 06.17.25 | United States Treasury Bills 0% | 7.08% |
| 5 | n/a | Cte ? Proshares Trust M | 6.89% |
| 6 | VRTX | Vertex Pharmaceuticals Incorporated | 6.33% |
| 7 | GILD | Gilead Sciences, Inc. | 6.21% |
| 8 | AMGN | Amgen Inc. | 6.14% |
| 9 | REGN | Regeneron Pharmaceuticals, Inc. | 5.53% |
| 10 | AZN | AstraZeneca PLC | 3.47% |
| 11 | ALNY | Alnylam Pharmaceuticals, Inc. | 3.12% |
| 12 | n/a | Cash | 2.25% |
| 13 | B.0 06.26.25 | United States Treasury Bills 0% | 1.77% |
| 14 | BIIB | Biogen Inc. | 1.58% |
| 15 | ARGX | argenx SE | 1.53% |
| 16 | SMMT | Summit Therapeutics Inc. | 1.51% |
| 17 | SNY | Sanofi | 1.27% |
| 18 | RPRX | Royalty Pharma plc | 1.26% |
| 19 | UTHR | United Therapeutics Corporation | 1.21% |
| 20 | EXEL | Exelixis, Inc. | 1.12% |
| 21 | ILMN | Illumina, Inc. | 1.11% |
| 22 | INSM | Insmed Incorporated | 1.07% |
| 23 | NBIX | Neurocrine Biosciences, Inc. | 1.07% |
| 24 | INCY | Incyte Corporation | 1.06% |
| 25 | BMRN | BioMarin Pharmaceutical Inc. | 1.01% |
| View BIB holdings | |||